British pharma opens U.S. headquarters in Boston


A British pharmaceutical company has opened a U.S. headquarters in Boston's Seaport District on the eve of two major late-stage trials.

Previous Norton Healthcare acquiring full ownership of Clark Memorial Health and Scott Memorial Health
Next Reboot Beverages revives Mount Pleasant whiskey history